Primate Study Identifies HIV Vaccine Candidates
Scientists reported that they have developed a vaccine that reduced monkeys' risk of becoming infected from simian immunodeficiency virus, or SIV – the monkey equivalent of HIV – by 80 percent per exposure.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter